Erste Asset Management Gmb H Alx Oncology Holdings Inc Transaction History

Erste Asset Management Gmb H

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Nov 22, 2024	SELL	$13.65 - $22.06 $125,580 - $202,952	-9,200 Closed	0 $0
Q4 2021 Nov 22, 2024	BUY	$21.49 - $74.4 $197,708 - $684,480	9,200 New	9,200 $202 Million
Q4 2020 Nov 22, 2024	BUY	$34.11 - $112.26 $313,812 - $1.03 Million	9,200 New	9,200 $776 Million

100

39.7M

134K

17.4K

Ticker ALXO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,747,100
Market Cap $59.5M
Description
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...

Get notified when there are updates to the investment portfolio of Erste Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Erste Asset Management Gmb H with notifications on news.